Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Autoimmune haemolytic anaemias: A retrospective study of 93 patients.

Gutiérrez Jomarrón I, López Rubio M, Morado Arias M, Arrizabalaga B, de la Iglesia S, Beneitez D, Sáez MI, Cervera A, Recasens V, Herrera A, Villegas AM; Grupo Español de Eritropatología.

Med Clin (Barc). 2019 Sep 2. pii: S0025-7753(19)30512-3. doi: 10.1016/j.medcli.2019.06.024. [Epub ahead of print] English, Spanish.

PMID:
31488259
2.

C>A substitution in NT 46 of the 3' UTR region (the α complex protected region) of the alpha-1 globin gene: a non-deletional mutation or polymorphism?

Ropero P, González FA, Nieto JM, Villegas A, Sevilla J, Pérez G, Alonso JM, Recasens V, Abio M, Vagace JM, Vanegas RJ, González Fernández B, Martínez R.

J Clin Pathol. 2019 Aug 21. pii: jclinpath-2019-206004. doi: 10.1136/jclinpath-2019-206004. [Epub ahead of print]

PMID:
31434698
3.

Capillary electrophoresis and mutational images of hemoglobin sendagi [Β42 (CD1) PHE → VAL; HBB: C.127T→G].

Recasens V, Ropero P, Lacalle L, Rodríguez-Vigil C, Montañés A, González FA, Pinzón S, Paúl P, Yus F, Rubio R, Díez R, Gómez A, Bustamante E.

Clin Biochem. 2019 Sep;71:69-71. doi: 10.1016/j.clinbiochem.2019.07.006. Epub 2019 Jul 9.

PMID:
31299317
4.

Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study.

Barbui T, Ghirardi A, Masciulli A, Carobbio A, Palandri F, Vianelli N, De Stefano V, Betti S, Di Veroli A, Iurlo A, Cattaneo D, Delaini F, Bonifacio M, Scaffidi L, Patriarca A, Rumi E, Casetti IC, Stephenson C, Guglielmelli P, Elli EM, Palova M, Bertolotti L, Erez D, Gomez M, Wille K, Perez-Encinas M, Lunghi F, Angona A, Fox ML, Beggiato E, Benevolo G, Carli G, Cacciola R, McMullin MF, Tieghi A, Recasens V, Marchetti M, Griesshammer M, Alvarez-Larran A, Vannucchi AM, Finazzi G.

Leukemia. 2019 Aug;33(8):1996-2005. doi: 10.1038/s41375-019-0487-8. Epub 2019 May 29.

PMID:
31142846
5.

High prognostic value of measurable residual disease detection by flow cytometry in chronic lymphocytic leukemia patients treated with front-line fludarabine, cyclophosphamide, and rituximab, followed by three years of rituximab maintenance.

García-Marco JA, Jiménez JL, Recasens V, Zarzoso MF, González-Barca E, De Marcos NS, Ramírez MJ, Parraga FJP, Yañez L, De La Serna Torroba J, Malo MDG, Ariznavarreta GD, Persona EP, Guinaldo MAR, De Paz Arias R, Llanos EB, Jarque I, Valle MDCF, Tatay AC, De Oteyza JP, Martin EMD, Fernández IP, Martinez RM, Costa MAA, Champ D, Suarez JG, Díaz MG, Ferrer S, Carbonell F, García-Vela JA; GELLC Study Group.

Haematologica. 2019 Nov;104(11):2249-2257. doi: 10.3324/haematol.2018.204891. Epub 2019 Mar 19.

6.

Lead poisoning as final diagnosis in a study of normocytic anemia.

Recasens V, Montañés A, Bustamante E.

Int J Hematol. 2019 Feb;109(2):135-136. doi: 10.1007/s12185-018-02570-1. Epub 2018 Dec 6. No abstract available.

PMID:
30523501
7.

Efficacy of repeated phlebotomies in hypertriglyceridemia and iron overload: A prospective, randomized, controlled trial.

Mateo-Gallego R, Lacalle L, Pérez-Calahorra S, Marco-Benedí V, Recasens V, Padrón N, Lamiquiz-Moneo I, Baila-Rueda L, Jarauta E, Calmarza P, Cenarro A, Civeira F.

J Clin Lipidol. 2018 Sep - Oct;12(5):1190-1198. doi: 10.1016/j.jacl.2018.06.017. Epub 2018 Jul 4.

PMID:
30049591

Supplemental Content

Loading ...
Support Center